Investors should prioritize Eli Lilly (LLY) as a high-conviction play on the "obesity trade," specifically watching for catalysts surrounding the next-generation weight loss drug Retatrutide. For exposure to the "In Real Life" entertainment narrative, AMC Entertainment (AMC) is a target for 2026 due to a record-breaking movie slate, while Carrier Global (CARR) offers a unique momentum trade on the rising demand for air conditioning in Europe. In the AI sector, Anthropic is the preferred private target over OpenAI due to a likely 2027 IPO delay, while hardware providers like Intel (INTC) and Micron (MU) are positioned to benefit from increased government regulation. The Biotech ETF (IBB) is currently showing a technical breakout, and Butterfly Network (BFLY) provides a niche entry into AI-driven medical imaging hardware. Within crypto, avoid "catching the falling knife" on Bitcoin (BTC) unless it hits the $48k-$50k range, and consider rotating out of MicroStrategy (MSTR) as its price premium over its holdings is expected to collapse.

This analysis summarizes investment themes, specific stock/crypto mentions, and actionable insights from the threadguy podcast episode regarding government AI regulation, the "IRL" trade, and shifting market sentiment.

OpenAI / Anthropic (AI Sector)

The discussion centered on a major shift in how AI models are released to the public, following reports that the U.S. government requested OpenAI to stagger the release of GPT-5.6 due to security concerns.

• Government Gatekeeping: The era of "finish a model and launch it" is over. Future models from OpenAI, Anthropic, and Google (Gemini) will likely undergo federal review, creating a "staggered" release schedule.
• Widening Intelligence Gap: There is a growing concern that the government and "select winners" will have access to models several generations ahead of what is available to the general public.
• Talent Wars: Anthropic is reportedly "mogging" (outperforming) OpenAI in talent acquisition. OpenAI pushing its IPO back to 2027 is viewed as a blow to employee morale, potentially leading to a mass exodus of researchers toward Anthropic for near-term liquidity.
• Model Names: Mention of new OpenAI model names: Luna, Terra, and Soul (noted for their similarity to crypto project names).

Takeaways

• Selective Capitalism: Watch for the government to "pick winners" by granting elite access to advanced AI. Companies mentioned as potential beneficiaries of government alignment include Intel (INTC), Micron (MU), IBM, and Dell.
• IPO Delay: OpenAI is leaning toward a 2027 IPO. This makes Anthropic the primary target for investors looking for a near-term AI lab IPO.
• Short-Term Bearishness on "Wrappers": Assets like Vesta (VVV) are viewed as "wrappers" that don't own their own weights/models, making them less valuable in a regime of strict government control over the underlying intelligence.

AMC Entertainment (AMC) & The "IRL" Trade

Despite dilution and poor management, the speaker remains "long" on the "In Real Life" (IRL) entertainment narrative.

• 2026 Movie Slate: Described as potentially the greatest lineup in history, featuring Spider-Man, Avengers, Toy Story 5, Super Mario Galaxy, and a new Christopher Nolan film.
• The "Mashing of Eras": High-budget legacy sequels are colliding with "Internet-based" indie films like Backrooms and Obsession, which are performing well on tiny budgets.
• StubHub: Mentioned as a key pick for the IRL trade, specifically as a "short" opportunity according to some analysts, though the speaker remains focused on the long side of the theme.

Takeaways

• Long AMC/IRL: The investment thesis is driven by "attention narrative" rather than pure economics. If the 2026 movie slate delivers, the speaker believes the trade will work regardless of current dilution.
• Avoid the "Sphere": The speaker expressed skepticism toward Sphere Entertainment (SPHR), calling it a "billion-dollar house plant," despite its recent price appreciation.

Carrier Global (CARR) & European Heat

A discussion on the lack of air conditioning in Europe and the high mortality rate from heatwaves compared to the U.S.

• Regulation & Infrastructure: Europe’s lack of AC is attributed to high electricity costs, older building regulations, and a "climate emergency" stigma against cooling units.
• Market Momentum: Carrier Global is noted for its strong short-term momentum and leadership transition in its European Climate Solutions segment.

Takeaways

• The "AC Long": Carrier Global (CARR) is identified as the primary public vehicle to play the potential "forced" adoption of air conditioning in Europe as temperatures rise.
• Risk Factor: High European energy prices remain the primary barrier to mass adoption, making this a "regulation-dependent" trade.

Bitcoin (BTC) & Solana (SOL)

The sentiment on the crypto market is currently defensive and cautious.

• Bitcoin (BTC): The speaker is avoiding "hero" bottom-sniping. The chart is "hammering" the $60,000 level.
• Solana (SOL): Viewed as being closer to a bottom than Bitcoin, but still faces skepticism as being "just a chain for meme coins."
• MicroStrategy (MSTR): The speaker expects the "MSTR Premium" (the price of the stock relative to its Bitcoin holdings) to collapse as ETFs make it easier for investors to buy Bitcoin directly.

Takeaways

• Wait for Strength: Actionable levels for Bitcoin are mentioned as "above $80k" (to confirm a narrative shift) or "wicking into $48k-$50k" for a deep value buy.
• Pump.fun (PUMP): Despite being down 80%+, it is viewed as a "successful crypto company" making $1B in revenue. The takeaway is to watch for a potential airdrop to restore "goodwill" and trigger a reversal.
• Arthur Hayes/Liquid Markets: A bullish nod to Arthur Hayes buying tokens on the liquid market (like Kalycoin/CARD) rather than VCs dumping "infra garbage" on retail.

Healthcare & Bio-Tech

• Eli Lilly (LLY): High conviction in Eli Lilly due to the "Holy Grail" of weight loss drugs (GLP-1s).
• Retatrutide (Retra): Mentioned as the next "gold mine" drug. While approval might be pushed to 2027, it is the primary catalyst for the sector.
• Midjourney Medical: The AI image generator is pivoting into "Ultrasonic CT" scanners and "Medical Spas."
• Butterfly Network (BFLY): Mentioned as the company that actually makes the chips for the type of handheld/ultrasound tech Midjourney is proposing.

Takeaways

• Long Bio-Tech (IBB): The IBB (Biotech ETF) is showing a "clean breakout" on the charts.
• The "Obesity Trade": Solving obesity is viewed as the ultimate health optimization trade. Eli Lilly remains the top pick here.